Evidence map›Paper›PMID 40771846›Full record

ArticleActa naturae

Two Key Substitutions in the Chromophore Environment of mKate2 Produce an Enhanced FusionRed-like Red Fluorescent Protein.

D A Ruchkin, A S Gavrikov, D V Kolesov, A Yu Gorokhovatsky, T V Chepurnykh, A S Mishin, E G Maksimov, N V Pletneva, V Z Pletnev, A M Pavlova and 2 more

Abstract read
In one paragraph

Article in Acta naturae. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

D A RuchkinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997 Russia.
A S GavrikovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997 Russia.
D V KolesovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997 Russia.
A Yu GorokhovatskyShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997 Russia.
T V ChepurnykhShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997 Russia.
A S MishinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997 Russia.
E G MaksimovFaculty of Biology, M.V. Lomonosov Moscow State University, Moscow,119992 Russia.
N V PletnevaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997 Russia.
V Z PletnevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997 Russia.
A M PavlovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997 Russia.
V A NikitinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997 Russia.
A M BogdanovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, 117997 Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Red fluorescent proteins (RFPs) are often probes of choice for living tissue microscopy and whole-body imaging. When choosing a specific RFP variant, the priority may be given to the fluorescence brightness, maturation rate, monomericity, excitation/emission wavelengths, and low toxicity, which are rarely combined in an optimal way in a single protein. If additional requirements such as prolonged fluorescence lifetime and/or blinking ability are applied, the available repertoire of probes could dramatically narrow. Since the entire diversity of conventional single-component RFPs belongs to just a few phylogenetic lines (DsRed-, eqFP578- and eqFP611-derived being the major ones), it is not unexpected that their advantageous properties are split between close homologs. In such cases, a systematic mutagenetic analysis focusing on variant-specific amino acid residues can shed light on the origins of the distinctness between related RFPs and may aid in consolidating their strengths in new RFP variants. For instance, the protein FusionRed, despite being efficient in fluorescence labeling thanks to its good monomericity and low cytotoxicity, has undergone considerable loss in fluorescence brightness/lifetime compared to the parental mKate2. In this contribution, we describe a fast-maturing monomeric RFP designed semi-rationally based on the mKate2 and FusionRed templates that outperforms both its parents in terms of molecular brightness, has extended fluorescence lifetime, and displays a spontaneous blinking pattern that is promising for nanoscopy use.

Indexed as

fluorescence lifetimefluorescent proteinFusionRedmKate2RFP

Identifiers

PMID40771846
PMCPMC12322884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.